Helena Cramer Veiga Rey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helena Cramer Veiga Rey has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Valéria Gonçalves da Silva
Instituto Nacional de Cardiologia, Brasil
4 shared publications - Ana Carla Dantas Cavalcanti
Universidade Federal Fluminense
3 shared publications - Eliza de Oliveira Baraúna
Instituto Nacional de Cardiologia, Brasil
3 shared publications - Simone Pereira Lermontov
Instituto Nacional de Cardiologia, Brasil
3 shared publications - Adriana Bastos Carvalho
Universidade Federal do Rio de Janeiro
2 shared publications - Beatriz Fernandes Dias
Universidade Federal Fluminense
2 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 39
Transcatheter Aortic Valve Implantation in Nonagenarians: In-Hospital Complications and One-Year Follow-Up Mortality
Background: Aortic Stenosis (AS) is prevalent among elderly individuals and is associated with high mortality when untreated. Transcatheter Aortic Valve Implantation (TAVI) has emerged as a viable therapeutic alternative, particularly for patients with surgical contraindications. However, its application in nonagenarians remains controversial due to limited data in this very elderly population. Objective: To evaluate clinical outcomes in nonagenarian patients undergoing TAVI at a private quaternary hospital, with emphasis on mortality and in-hospital as well as one-year complications. Methods: A [...] Abstract Background: Aortic Stenosis (AS) is prevalent among elderly individuals and is associated with high mortality when untreated. Transcatheter Aortic Valve Implantation (TAVI) has emerged as a viable therapeutic alternative, particularly for patients with surgical contraindications. However, its application in nonagenarians remains controversial due to limited data in this very elderly population. Objective: To evaluate clinical outcomes in nonagenarian patients undergoing TAVI at a private quaternary hospital, with emphasis on mortality and in-hospital as well as one-year complications. Methods: A
- 31 August 2026
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 39
Open AccessTranscatheter Aortic Valve Implantation in Nonagenarians: In-Hospital Complications and One-Year Follow-Up Mortality
Background: Aortic Stenosis (AS) is prevalent among elderly individuals and is associated with high mortality when untreated. Transcatheter Aortic Valve Implantation (TAVI) has emerged as a viable therapeutic alternative, particularly for patients with surgical contraindications. However, its application in nonagenarians remains controversial due to limited data in this very elderly population. Objective: To evaluate clinical outcomes in nonagenarian patients undergoing TAVI at a private quaternary hospital, with emphasis on mortality and in-hospital as well as one-year complications. Methods: A [...] Abstract Background: Aortic Stenosis (AS) is prevalent among elderly individuals and is associated with high mortality when untreated. Transcatheter Aortic Valve Implantation (TAVI) has emerged as a viable therapeutic alternative, particularly for patients with surgical contraindications. However, its application in nonagenarians remains controversial due to limited data in this very elderly population. Objective: To evaluate clinical outcomes in nonagenarian patients undergoing TAVI at a private quaternary hospital, with emphasis on mortality and in-hospital as well as one-year complications. Methods: A
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 35
DIMENSÕES DA QUALIDADE DE VIDA EM PACIENTES COM INSUFICIÊNCIA CARDÍACA E SARCOPENIA: REVISÃO DE ESCOPO
RESUMO Objetivo: mapear as evidências existentes sobre as dimensões da qualidade de vida em pacientes com insuficiência cardíaca e sarcopenia. Método: esta revisão de escopo seguiu o Manual do JBI para Síntese de Evidências. Foram selecionados estudos publicados entre 2011 e 2023 em 15 bases de dados, totalizando inicialmente 7.703 artigos. Após a aplicação dos critérios de elegibilidade, sete estudos foram incluídos. A busca foi realizada em setembro de 2023, com atualização em dezembro de 2024. Resultados: os estudos identificaram dimensões-chave da qualidade de vida afetadas pela sarcopenia em pacientes com insuficiência cardíaca, incluindo capacidade funcional, capacidade de exercício, mobilidade, dor/desconforto e aspectos emocionais e sociais. A qualidade de vida foi avaliada por meio de instrumentos como o Short Form-36, o EuroQol 5-Dimensions e o Kansas City Cardiomyopathy Questionnaire. As capacidades funcional e de exercício foram as mais frequentemente relatadas como prejudicadas. Conclusão: a qualidade de vida em pacientes com insuficiência cardíaca e sarcopenia é primariamente impactada pela capacidade funcional e pela capacidade de exercício, sendo necessárias intervenções direcionadas para melhorar essas dimensões.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 35
Open AccessDIMENSÕES DA QUALIDADE DE VIDA EM PACIENTES COM INSUFICIÊNCIA CARDÍACA E SARCOPENIA: REVISÃO DE ESCOPO
RESUMO Objetivo: mapear as evidências existentes sobre as dimensões da qualidade de vida em pacientes com insuficiência cardíaca e sarcopenia. Método: esta revisão de escopo seguiu o Manual do JBI para Síntese de Evidências. Foram selecionados estudos publicados entre 2011 e 2023 em 15 bases de dados, totalizando inicialmente 7.703 artigos. Após a aplicação dos critérios de elegibilidade, sete estudos foram incluídos. A busca foi realizada em setembro de 2023, com atualização em dezembro de 2024. Resultados: os estudos identificaram dimensões-chave da qualidade de vida afetadas pela sarcopenia em pacientes com insuficiência cardíaca, incluindo capacidade funcional, capacidade de exercício, mobilidade, dor/desconforto e aspectos emocionais e sociais. A qualidade de vida foi avaliada por meio de instrumentos como o Short Form-36, o EuroQol 5-Dimensions e o Kansas City Cardiomyopathy Questionnaire. As capacidades funcional e de exercício foram as mais frequentemente relatadas como prejudicadas. Conclusão: a qualidade de vida em pacientes com insuficiência cardíaca e sarcopenia é primariamente impactada pela capacidade funcional e pela capacidade de exercício, sendo necessárias intervenções direcionadas para melhorar essas dimensões.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 35
QUALITY-OF-LIFE DIMENSIONS IN PATIENTS WITH HEART FAILURE AND SARCOPENIA: A SCOPING REVIEW
Objective: to map the existing evidence on the quality-of-life dimensions in patients with heart failure and sarcopenia. Method: this scoping review followed the JBI Evidence Synthesis Manual. Studies published between 2011 and 2023 in 15 databases were selected, initially totaling 7,703 articles. After applying the eligibility criteria, seven studies were included. The search was conducted in September 2023, with an update in December 2024. Results: the studies identified key dimensions of quality of life affected by sarcopenia in patients with heart failure, including functional capacity, exercise capacity, mobility, pain/discomfort, and emotional and social aspects. Quality of life was assessed using instruments such as the Short Form-36, the EuroQol 5-Dimensions, and the Kansas City Cardiomyopathy Questionnaire. Functional and exercise capacities were the most frequently reported as impaired. Conclusion: quality of life in patients with heart failure and sarcopenia is primarily impacted by functional capacity and exercise capacity, requiring targeted interventions to improve these dimensions.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Texto & Contexto - Enfermagem
- Vol. 35
Open AccessQUALITY-OF-LIFE DIMENSIONS IN PATIENTS WITH HEART FAILURE AND SARCOPENIA: A SCOPING REVIEW
Objective: to map the existing evidence on the quality-of-life dimensions in patients with heart failure and sarcopenia. Method: this scoping review followed the JBI Evidence Synthesis Manual. Studies published between 2011 and 2023 in 15 databases were selected, initially totaling 7,703 articles. After applying the eligibility criteria, seven studies were included. The search was conducted in September 2023, with an update in December 2024. Results: the studies identified key dimensions of quality of life affected by sarcopenia in patients with heart failure, including functional capacity, exercise capacity, mobility, pain/discomfort, and emotional and social aspects. Quality of life was assessed using instruments such as the Short Form-36, the EuroQol 5-Dimensions, and the Kansas City Cardiomyopathy Questionnaire. Functional and exercise capacities were the most frequently reported as impaired. Conclusion: quality of life in patients with heart failure and sarcopenia is primarily impacted by functional capacity and exercise capacity, requiring targeted interventions to improve these dimensions.
- Open Access
- 21 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0300918
Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol
Sarcopenia, a clinical syndrome primarily associated with reduced muscle mass in the elderly, has a negative impact on quality of life and survival. It can occur secondarily to other diseases such as heart failure (HF), a complex clinical syndrome with high morbidity and mortality. The simultaneous occurrence of these two conditions can worsen the prognosis of their carriers, especially in the most severe cases of HF, as in patients with reduced left ventricular ejection fraction (LVEF). However, due to the heterogeneous diagnostic criteria for sarcopenia, estimates of its prevalence present a wide variation, leading to new criteria having been recently proposed for its diagnosis, emphasizing muscle strength and function rather than skeletal muscle mass. The primary objective of this study is to evaluate the prevalence of sarcopenia and/or dynapenia in individuals with HF with reduced LVEF according to the most recent criteria, and compare the gene and protein expression of those patients with and without sarcopenia. The secondary objectives are to evaluate the association of sarcopenia and/or dynapenia with the risk of clinical events and death, quality of life, cardiorespiratory capacity, ventilatory efficiency, and respiratory muscle strength. The participants will answer questionnaires to evaluate sarcopenia and quality of life, and will undergo the following tests: handgrip strength, gait speed, dual-energy X-ray absorptiometry, respiratory muscle strength, cardiopulmonary exercise, as well as genomic and proteomic analysis, and dosage of N-terminal pro-B-type natriuretic peptide and growth differentiation factor-15. An association between sarcopenia and/or dynapenia with unfavorable clinical evolution is expected to be found, in addition to reduced quality of life, cardiorespiratory capacity, ventilatory efficiency, and respiratory muscle strength.
- 21 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0300918
Open AccessPrevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol
Sarcopenia, a clinical syndrome primarily associated with reduced muscle mass in the elderly, has a negative impact on quality of life and survival. It can occur secondarily to other diseases such as heart failure (HF), a complex clinical syndrome with high morbidity and mortality. The simultaneous occurrence of these two conditions can worsen the prognosis of their carriers, especially in the most severe cases of HF, as in patients with reduced left ventricular ejection fraction (LVEF). However, due to the heterogeneous diagnostic criteria for sarcopenia, estimates of its prevalence present a wide variation, leading to new criteria having been recently proposed for its diagnosis, emphasizing muscle strength and function rather than skeletal muscle mass. The primary objective of this study is to evaluate the prevalence of sarcopenia and/or dynapenia in individuals with HF with reduced LVEF according to the most recent criteria, and compare the gene and protein expression of those patients with and without sarcopenia. The secondary objectives are to evaluate the association of sarcopenia and/or dynapenia with the risk of clinical events and death, quality of life, cardiorespiratory capacity, ventilatory efficiency, and respiratory muscle strength. The participants will answer questionnaires to evaluate sarcopenia and quality of life, and will undergo the following tests: handgrip strength, gait speed, dual-energy X-ray absorptiometry, respiratory muscle strength, cardiopulmonary exercise, as well as genomic and proteomic analysis, and dosage of N-terminal pro-B-type natriuretic peptide and growth differentiation factor-15. An association between sarcopenia and/or dynapenia with unfavorable clinical evolution is expected to be found, in addition to reduced quality of life, cardiorespiratory capacity, ventilatory efficiency, and respiratory muscle strength.
- 1 January 2024
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 18, 1-5
Dimensions of quality of life in patients with heart failure and sarcopenia: a scoping review protocol
Objective: To map the dimensions of quality of life in patients with heart failure (HF) and sarcopenia. Methods: The scoping review will adhere to the JBI Manual for Evidence Synthesis methodology and will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). Searches will encompass MEDLINE/PubMed, SCOPUS, EMBASE/Elsevier, LILACS, IBECS, BDENF (BVS), SciELO, Core Collection (Clarivate Analytics), CINAHL, Academic Search Premier (EBSCO), PsycINFO (APA), Cochrane Library, Epistemonikos, and academic search engines: Google Scholar and Bielefeld Academic Search Engine (BASE), without language or date restrictions. Inclusion criteria: Population — adults with HF and sarcopenia; Concept — Dimensions of quality of life including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression — defined based on the EQ-5D-3L questionnaire; Context — any health care setting. Two independent reviewers will select studies and extract data, with a third reviewer consulted in cases of discrepancies. Findings will be presented graphically with a narrative summary. Expected results: We aim to uncover key dimensions of quality of life in individuals with HF and sarcopenia through this scoping review. Anticipated outcomes include insights into mobility, self-care, usual activities, pain/discomfort, and anxiety/depression across diverse health care settings. Relevance: This review sheds light on the interplay between HF and sarcopenia and its impact on quality of life. The findings may guide interventions, inform evidence-based decision-making, and contribute to targeted strategies to improve the wellbeing of individuals managing both conditions. Review registration: Open Science Framework [https://archive.org/details/osf-registrations-jn387-v1].
- 1 January 2024
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 18, 1-5
Dimensions of quality of life in patients with heart failure and sarcopenia: a scoping review protocol
Objective: To map the dimensions of quality of life in patients with heart failure (HF) and sarcopenia. Methods: The scoping review will adhere to the JBI Manual for Evidence Synthesis methodology and will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). Searches will encompass MEDLINE/PubMed, SCOPUS, EMBASE/Elsevier, LILACS, IBECS, BDENF (BVS), SciELO, Core Collection (Clarivate Analytics), CINAHL, Academic Search Premier (EBSCO), PsycINFO (APA), Cochrane Library, Epistemonikos, and academic search engines: Google Scholar and Bielefeld Academic Search Engine (BASE), without language or date restrictions. Inclusion criteria: Population — adults with HF and sarcopenia; Concept — Dimensions of quality of life including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression — defined based on the EQ-5D-3L questionnaire; Context — any health care setting. Two independent reviewers will select studies and extract data, with a third reviewer consulted in cases of discrepancies. Findings will be presented graphically with a narrative summary. Expected results: We aim to uncover key dimensions of quality of life in individuals with HF and sarcopenia through this scoping review. Anticipated outcomes include insights into mobility, self-care, usual activities, pain/discomfort, and anxiety/depression across diverse health care settings. Relevance: This review sheds light on the interplay between HF and sarcopenia and its impact on quality of life. The findings may guide interventions, inform evidence-based decision-making, and contribute to targeted strategies to improve the wellbeing of individuals managing both conditions. Review registration: Open Science Framework [https://archive.org/details/osf-registrations-jn387-v1].
- Open Access
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (6)
Brazilian Society of Cardiology Guidelines: New Norms, New Challenges
Diretrizes na Sociedade Brasileira de Cardiologia As primeiras diretrizes da Sociedade Brasileira de Cardiologia (SBC) surgiram também nas décadas de 1980 e 1990, abordando as questões relacionadas ao diagnóstico e tratamento das doenças cardiovasculares prevalentes, como hipertensão arterial, doença arterial coronariana e insuficiência cardíaca. Em 2006, foi instituído o Conselho de Normatizações e Diretrizes (ConDir) da SBC, responsável por coordenar a elaboração de diretrizes e normas técnicas para orientar a prática clínica dos cardiologistas brasileiros. Assim como para outras sociedades [...] Diretrizes na Sociedade Brasileira de Cardiologia As primeiras diretrizes da Sociedade Brasileira de Cardiologia (SBC) surgiram também nas décadas de 1980 e 1990, abordando as questões relacionadas ao diagnóstico e tratamento das doenças cardiovasculares prevalentes, como hipertensão arterial, doença arterial coronariana e insuficiência cardíaca. Em 2006, foi instituído o Conselho de Normatizações e Diretrizes (ConDir) da SBC, responsável por coordenar a elaboração de diretrizes e normas técnicas para orientar a prática clínica dos cardiologistas brasileiros. Assim como para outras sociedades
- 1 January 2024
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (6)
Open AccessBrazilian Society of Cardiology Guidelines: New Norms, New Challenges
Diretrizes na Sociedade Brasileira de Cardiologia As primeiras diretrizes da Sociedade Brasileira de Cardiologia (SBC) surgiram também nas décadas de 1980 e 1990, abordando as questões relacionadas ao diagnóstico e tratamento das doenças cardiovasculares prevalentes, como hipertensão arterial, doença arterial coronariana e insuficiência cardíaca. Em 2006, foi instituído o Conselho de Normatizações e Diretrizes (ConDir) da SBC, responsável por coordenar a elaboração de diretrizes e normas técnicas para orientar a prática clínica dos cardiologistas brasileiros. Assim como para outras sociedades [...] Diretrizes na Sociedade Brasileira de Cardiologia As primeiras diretrizes da Sociedade Brasileira de Cardiologia (SBC) surgiram também nas décadas de 1980 e 1990, abordando as questões relacionadas ao diagnóstico e tratamento das doenças cardiovasculares prevalentes, como hipertensão arterial, doença arterial coronariana e insuficiência cardíaca. Em 2006, foi instituído o Conselho de Normatizações e Diretrizes (ConDir) da SBC, responsável por coordenar a elaboração de diretrizes e normas técnicas para orientar a prática clínica dos cardiologistas brasileiros. Assim como para outras sociedades
- Open Access
Toward Precision Medicine in Aortopathies: Genetic Insights from a Brazilian Cohort Through Targeted Next-Generation Sequencing
Thoracic aortic diseases (or aortopathies) result from complex interactions between genetic and hemodynamic factors. Often clinically silent, these diseases can lead to lethal complications like aortic dissection or rupture. This study focused on a Brazilian cohort of 79 individuals with thoracic aortic diseases, exploring genetic factors through targeted next-generation sequencing (tNGS) of 15 priority genes. The majority of individuals had non-syndromic aortopathy, with eight diagnosed with Marfan syndrome (MFS). Pathogenic or likely pathogenic variants (PV/LPV) were found in five genes, including FBN1, ACTA2, TGFBR2, MYLK, and SMAD3. Notably, novel variants in FBN1 were identified, contributing to Marfan-like phenotypes. The diagnostic yield for isolated aortopathies was 7.1%, rising to 55.5% for syndromic cases. Variants of uncertain significance (VUS) were identified, emphasizing the need for further research and familial investigations to refine variant classifications. This study provides valuable insights into the genetic landscape of aortopathies in Brazil, aiding early diagnosis and personalized management.
Open AccessToward Precision Medicine in Aortopathies: Genetic Insights from a Brazilian Cohort Through Targeted Next-Generation Sequencing
Thoracic aortic diseases (or aortopathies) result from complex interactions between genetic and hemodynamic factors. Often clinically silent, these diseases can lead to lethal complications like aortic dissection or rupture. This study focused on a Brazilian cohort of 79 individuals with thoracic aortic diseases, exploring genetic factors through targeted next-generation sequencing (tNGS) of 15 priority genes. The majority of individuals had non-syndromic aortopathy, with eight diagnosed with Marfan syndrome (MFS). Pathogenic or likely pathogenic variants (PV/LPV) were found in five genes, including FBN1, ACTA2, TGFBR2, MYLK, and SMAD3. Notably, novel variants in FBN1 were identified, contributing to Marfan-like phenotypes. The diagnostic yield for isolated aortopathies was 7.1%, rising to 55.5% for syndromic cases. Variants of uncertain significance (VUS) were identified, emphasizing the need for further research and familial investigations to refine variant classifications. This study provides valuable insights into the genetic landscape of aortopathies in Brazil, aiding early diagnosis and personalized management.
- 1 June 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 3 (1)
National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System
The Brazilian National Network of Cardiovascular Genomics (RENOMICA) is a research project whose objective is to establish a proof of concept that genetic diagnosis for hereditary cardiovascular diseases is important, feasible, and cost-effective within the Brazilian Unified Health System (SUS). Funded by the Brazilian National Genomics and Precision Health Program (Genomas Brasil) of the Ministry of Health, the study is coordinated by the Brazilian National Institute of Cardiology (INC), with 21 co-participating centers throughout the country. Recruitment, which began in [...] The Brazilian National Network of Cardiovascular Genomics (RENOMICA) is a research project whose objective is to establish a proof of concept that genetic diagnosis for hereditary cardiovascular diseases is important, feasible, and cost-effective within the Brazilian Unified Health System (SUS). Funded by the Brazilian National Genomics and Precision Health Program (Genomas Brasil) of the Ministry of Health, the study is coordinated by the Brazilian National Institute of Cardiology (INC), with 21 co-participating centers throughout the country. Recruitment, which began in
- 1 June 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 3 (1)
National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System
The Brazilian National Network of Cardiovascular Genomics (RENOMICA) is a research project whose objective is to establish a proof of concept that genetic diagnosis for hereditary cardiovascular diseases is important, feasible, and cost-effective within the Brazilian Unified Health System (SUS). Funded by the Brazilian National Genomics and Precision Health Program (Genomas Brasil) of the Ministry of Health, the study is coordinated by the Brazilian National Institute of Cardiology (INC), with 21 co-participating centers throughout the country. Recruitment, which began in [...] The Brazilian National Network of Cardiovascular Genomics (RENOMICA) is a research project whose objective is to establish a proof of concept that genetic diagnosis for hereditary cardiovascular diseases is important, feasible, and cost-effective within the Brazilian Unified Health System (SUS). Funded by the Brazilian National Genomics and Precision Health Program (Genomas Brasil) of the Ministry of Health, the study is coordinated by the Brazilian National Institute of Cardiology (INC), with 21 co-participating centers throughout the country. Recruitment, which began in
- Open Access
- 22 December 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 118 (3) , 578-585
Análise da Custo-Efetividade da Angiotomografia Coronariana no SUS, em Comparação com Outros Métodos Não Invasivos na Suspeita de DAC Estável
Resumo Fundamento Atualmente o sistema de saúde público brasileiro (SUS) não contempla a angiotomografia de coronárias. Objetivos Ranquear sob a perspectiva do SUS, a custo-efetividade de estratégias diagnósticas combinando teste ergométrico, cintilografia miocárdica, ecocardiograma por estresse e angiotomografia de coronárias para o diagnóstico de doença arterial coronariana em uma coorte hipotética de pacientes com probabilidade pré-teste intermediária. Métodos Análise de custo-efetividade por meio de árvore de decisão. Foram analisados a relação de custo-efetividade incremental e o benefício líquido em saúde [...] Resumo Fundamento Atualmente o sistema de saúde público brasileiro (SUS) não contempla a angiotomografia de coronárias. Objetivos Ranquear sob a perspectiva do SUS, a custo-efetividade de estratégias diagnósticas combinando teste ergométrico, cintilografia miocárdica, ecocardiograma por estresse e angiotomografia de coronárias para o diagnóstico de doença arterial coronariana em uma coorte hipotética de pacientes com probabilidade pré-teste intermediária. Métodos Análise de custo-efetividade por meio de árvore de decisão. Foram analisados a relação de custo-efetividade incremental e o benefício líquido em saúde
- 22 December 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 118 (3) , 578-585
Open AccessAnálise da Custo-Efetividade da Angiotomografia Coronariana no SUS, em Comparação com Outros Métodos Não Invasivos na Suspeita de DAC Estável
Resumo Fundamento Atualmente o sistema de saúde público brasileiro (SUS) não contempla a angiotomografia de coronárias. Objetivos Ranquear sob a perspectiva do SUS, a custo-efetividade de estratégias diagnósticas combinando teste ergométrico, cintilografia miocárdica, ecocardiograma por estresse e angiotomografia de coronárias para o diagnóstico de doença arterial coronariana em uma coorte hipotética de pacientes com probabilidade pré-teste intermediária. Métodos Análise de custo-efetividade por meio de árvore de decisão. Foram analisados a relação de custo-efetividade incremental e o benefício líquido em saúde [...] Resumo Fundamento Atualmente o sistema de saúde público brasileiro (SUS) não contempla a angiotomografia de coronárias. Objetivos Ranquear sob a perspectiva do SUS, a custo-efetividade de estratégias diagnósticas combinando teste ergométrico, cintilografia miocárdica, ecocardiograma por estresse e angiotomografia de coronárias para o diagnóstico de doença arterial coronariana em uma coorte hipotética de pacientes com probabilidade pré-teste intermediária. Métodos Análise de custo-efetividade por meio de árvore de decisão. Foram analisados a relação de custo-efetividade incremental e o benefício líquido em saúde
- Open Access
- 15 July 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 117 (1) , 49-50
A Importância de Reconhecer a Co-ocorrência de Fatores de Risco Cardiometabólico na População para Estabelecer Prioridades em Políticas Públicas
A doença cardiometabólica (DCM) é a principal causa de morbimortalidade em todo o mundo. A síndrome metabólica (SM) é um conjunto de fatores de risco para doenças metabólicas, incluindo pressão arterial elevada, hipertensão, hiperglicemia, dislipidemia e obesidade. Quando esses fatores de risco estão presentes em combinação, a probabilidade de futuros problemas cardiovasculares aumenta mais do que quando qualquer um dos riscos está presente sozinho. A SM tem uma frequência estimada entre 20% e 25% na população adulta em todo o
- 15 July 2021
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 117 (1) , 49-50
Open AccessA Importância de Reconhecer a Co-ocorrência de Fatores de Risco Cardiometabólico na População para Estabelecer Prioridades em Políticas Públicas
A doença cardiometabólica (DCM) é a principal causa de morbimortalidade em todo o mundo. A síndrome metabólica (SM) é um conjunto de fatores de risco para doenças metabólicas, incluindo pressão arterial elevada, hipertensão, hiperglicemia, dislipidemia e obesidade. Quando esses fatores de risco estão presentes em combinação, a probabilidade de futuros problemas cardiovasculares aumenta mais do que quando qualquer um dos riscos está presente sozinho. A SM tem uma frequência estimada entre 20% e 25% na população adulta em todo o